Skip to main content
DNA Labs India

C2CD3 Gene Orofaciodigital syndrome type 14 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

C2CD3 Gene Orofaciodigital syndrome type 14 NGS Genetic Test

Short Name: C2CD3 OFD14 NGS Test

Also known as: OFD14 Genetic Test, C2CD3 Gene Sequencing, Orofaciodigital Syndrome Type 14 NGS Panel

C2CD3 Gene Orofaciodigital syndrome type 14 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks from sample receipt at the laboratory.. Free home collection in 300+ cities across India.

NGS Gene Panel🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to confirm a clinical diagnosis of Orofaciodigital syndrome type 14 by identifying mutations in the C2CD3 gene. It is also used for carrier testing in at-risk family members and for prenatal diagnosis in families with known mutations.

Test Code
5886
CPT Code
81407
ICD Code
Q87.0
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks from sample receipt at the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation is required. However, a genetic counseling session is recommended before the test to discuss implications.

Method: Venipuncture or Finger-prick

Step 2

Laboratory Analysis

Blood sample is collected by a trained phlebotomist. For FTA card, a simple finger-prick is sufficient.

Step 3

Report Delivery

No restrictions. The sample is sent to the laboratory for analysis.

Timeline: 3 to 4 weeks from sample receipt at the laboratory.

Patient Instructions

1
Before the Test:No special preparation. Genetic counseling is advised to understand the implications of testing.
2
During the Test:A blood sample is drawn or a finger-prick is done for FTA card. The procedure is quick and minimally invasive.
3
After the Test:You can resume normal activities immediately. Results will be available in 3-4 weeks.

About This Test

Who Should Get This Test

The purpose of this test is to confirm a clinical diagnosis of Orofaciodigital syndrome type 14 by identifying mutations in the C2CD3 gene. It is also used for carrier testing in at-risk family members and for prenatal diagnosis in families with known mutations.

How to Prepare

  • Use EDTA vacutainer for blood collection
  • For FTA card, ensure the blood spot is completely dried before packaging
  • Label the sample with patient ID and date of collection
  • Transport at ambient temperature

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Early genetic confirmation of OFD14 is crucial for management and family counseling. This NGS test provides a definitive diagnosis, enabling timely intervention and recurrence risk assessment."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml blood or 1 drop on FTA card
ContainerEDTA vacutainer or FTA card
Collection MethodVenipuncture or Finger-prick

Sample Stability

Blood: 7 days at 2-8°C
Extracted DNA: 1 year at -20°C
FTA card: 6 months at room temperature
Sample Rejection Criteria:
  • Hemolyzed or clotted blood sample
  • Insufficient sample volume
  • Improperly labeled sample
  • Sample received after prolonged transit without proper storage

Understanding Your Results

The test results are interpreted by a clinical geneticist. A positive result confirms the diagnosis of OFD14, while a negative result does not completely rule out the condition if clinical suspicion is high.
📊

Pathogenic variant detected

Confirms diagnosis of OFD14. Autosomal recessive inheritance. Both parents are likely carriers.

📊

Likely pathogenic variant detected

Highly suggestive of OFD14; further family studies may be recommended.

📊

Variant of uncertain significance (VUS)

Cannot be definitively classified; additional testing or family segregation analysis may be needed.

📊

No pathogenic variant detected

No mutation found in C2CD3 gene; consider other genetic causes if symptoms persist.

⚠️ When to Consult a Doctor:

Consult a clinical geneticist or pediatrician if you or your child have features suggestive of OFD14, or if there is a family history of the condition. Genetic counseling is recommended before and after testing.

Limitations

  • This test only analyzes the C2CD3 gene; other genes associated with OFD syndromes are not covered.
  • Variant of uncertain significance (VUS) may require further family studies.
  • Large deletions/duplications may not be detected by standard NGS; additional testing may be needed.
  • Test does not assess non-coding regulatory regions.

Risks & Considerations

  • Minimal risk of bruising or infection at the blood draw site
  • Psychological impact of receiving genetic results
  • Potential for uncertain results (VUS)

Interfering Factors

  • Contaminated or degraded DNA sample
  • Insufficient sample quantity
  • Recent blood transfusion (may dilute DNA)
  • Bone marrow transplant (may affect results)

Compare With Similar Tests

TestC2CD3 Gene Orofaciodigital syndrome type 14 NGS Genetic TestWhole Exome Sequencing (WES)Chromosomal Microarray (CMA)Sanger Sequencing
ComparisonC2CD3 Gene Orofaciodigital syndrome type 14 NGS Genetic TestWES covers all coding regions of the genome, including C2CD3, but is more expensive and time-consuming. This targeted NGS test is cost-effective for suspected OFD14.CMA detects copy number changes but does not identify single nucleotide variants. This test is specific for C2CD3 mutations.Sanger is used for confirmation of specific variants but is not efficient for large genes. NGS is preferred for comprehensive analysis.

Frequently Asked Questions

What is Orofaciodigital syndrome type 14?
OFD14 is a rare genetic disorder caused by mutations in the C2CD3 gene, affecting facial, oral, and digit development. It is inherited in an autosomal recessive pattern.
How is the C2CD3 gene test performed?
The test uses Next-Generation Sequencing (NGS) to analyze the entire C2CD3 gene for mutations. A blood sample or FTA card blood spot is required.
What is the cost of the test?
The test costs INR 20,000, which includes sample collection, DNA extraction, NGS analysis, and genetic counseling.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after the sample reaches the laboratory.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for this test across many cities in India.
What sample types are accepted?
We accept blood in EDTA tube, extracted DNA, or one drop of blood on an FTA card.
Do I need to fast before the test?
No, fasting is not required for this genetic test.
Can this test detect all types of OFD syndromes?
No, this test specifically analyzes the C2CD3 gene for OFD14. Other OFD syndromes may require different gene panels.
What does a positive result mean?
A positive result indicates a pathogenic mutation in the C2CD3 gene, confirming the diagnosis of OFD14.
What if the result is negative?
A negative result means no mutation was found in the C2CD3 gene. However, clinical suspicion may warrant further testing for other genes.
Is genetic counseling included?
Yes, a genetic counseling session is included to help interpret results and discuss implications for the family.
Can this test be used for prenatal diagnosis?
Yes, if a familial mutation is known, this test can be used for prenatal diagnosis with appropriate counseling.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.